Steven C. Halladay
Keine laufenden Positionen mehr
Karriereverlauf von Steven C. Halladay
Ehemalige bekannte Positionen von Steven C. Halladay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DURECT CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2002 | 01.10.2006 |
General Counsel | 01.09.2002 | 01.10.2006 | |
Clingenix, Inc.
Clingenix, Inc. Miscellaneous Commercial ServicesCommercial Services Clingenix, Inc. provided pharmacogenomics services and diagnostic products. The company was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01.01.2000 | 01.01.2002 |
Research Services, Inc.
Research Services, Inc. Miscellaneous Commercial ServicesCommercial Services Research Services, Inc. provides clinical trials, regulatory affairs, compliance, and resource services to pharmaceutical companies. Research Services was acquired by Clingenix, Inc. on July 10, 2000. | Präsident | 01.01.1995 | 01.01.2001 |
QUESTCOR PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 16.10.2006 | - |
General Counsel | 16.10.2006 | - |
Ausbildung von Steven C. Halladay
Southern Utah University | Undergraduate Degree |
University of Arizona | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
General Counsel | 2 |
President | 1 |
Sektoral
Health Technology | 3 |
Commercial Services | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DURECT CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Clingenix, Inc.
Clingenix, Inc. Miscellaneous Commercial ServicesCommercial Services Clingenix, Inc. provided pharmacogenomics services and diagnostic products. The company was headquartered in Sunnyvale, CA. | Commercial Services |
Research Services, Inc.
Research Services, Inc. Miscellaneous Commercial ServicesCommercial Services Research Services, Inc. provides clinical trials, regulatory affairs, compliance, and resource services to pharmaceutical companies. Research Services was acquired by Clingenix, Inc. on July 10, 2000. | Commercial Services |
- Börse
- Insiders
- Steven C. Halladay
- Erfahrung